PW Medtech Group Ltd.

As of December 31, 2025, PW Medtech Group Ltd. carries a market capitalization of 1.90B, placing it among publicly traded companies globally. Its enterprise value stands at 916.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, PW Medtech Group Ltd. has 1.47B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, PW Medtech Group Ltd. maintains a current ratio of 10.89, meaning it holds 10.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, PW Medtech Group Ltd.'s stock has declined approximately 39.12% over the past 52 weeks. The 50-day moving average sits at 0.92, while the 200-day moving average is 1.11.

As of December 31, 2025, PW Medtech Group Ltd. holds 2.01B in cash and equivalents against 24.48M in total debt, resulting in a net debt position of -1.99B. Total book value stands at 4.40B, with working capital of 2.39B providing operational flexibility.